Please sign in to follow a disease.
Four days to heal trauma? group EMDR put to the test in migrants
NCT ID NCT07731906
First seen Jul 28, 2026 · Last updated Jul 29, 2026 · Updated 1 time
Summary
This pilot trial tests whether a brief group therapy called EMDR-IGTP-OTS can reduce posttraumatic stress symptoms in migrants attending an adult education center in Italy. Participants receive four structured group sessions on consecutive days and are compared with a control group. The study measures changes in PTSD symptoms and psychological distress to see if this short, scalable intervention could help a vulnerable population.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- a 4-session group behavioral therapy called EMDR-IGTP-OTS (Eye Movement Desensitization and Reprocessing Integrative Group Treatment Protocol for Ongoing Traumatic Stress)
- What this could lead to
- If effective, this brief group therapy could offer a scalable, low-cost way to reduce PTSD symptoms in migrant populations with limited access to mental health care.
- What could go wrong
- This is a small pilot study, so results may not be generalizable. The intervention is short and may not be sufficient for severe or complex trauma.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
185 people
The number who actually took part.
- Started
-
Dec 2025
- Finished
-
May 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
16 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Enrollment in courses at CPIA Salerno (adult education center). * Age ≥16 years. * Sufficient Italian or English language proficiency to complete study procedures. * Provision of informed consent. * Clinically significant posttraumatic stress symptoms, defined as an Impact of Event Scale-Revised (IES-R) score ≥24 or a Short PTSD Rating Interview (SPRINT) score ≥14 at baseline. Exclusion Criteria: * Current self-harm behavior or suicidal or homicidal ideation. * Substance abuse. * Psychotic disorders, bipolar disorders, or organic mental disorders. * Lack of adequate structural or functional support. * Significant cognitive impairment affecting participation in study procedures.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Posttraumatic stress disorder (PTSD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centro Provinciale Istruzione Adulti Salerno "Paulo Freire"
Salerno, Italy, 84131, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a phone app ease the mental toll of childhood trauma?
- Can ketamine boost mindfulness therapy for people facing pain and PTSD?
- Does a camera lens offer a path to calmer minds?
- Ancient music therapy put to the test against anxiety in pancreatic cancer
- Can a Psychedelic-Assisted therapy help veterans with PTSD?
- Can a psychedelic ease the existential weight of advanced cancer?